| S1979 |
Amiodarone HCl
|
Amiodarone HCl is a sodium/potassium-ATPase inhibitor and an autophagy activator, used to treat various types of cardiac dysrhythmias.
|
-
Cancer Cell, 2025, 43(4):776-796.e14
-
J Immunother Cancer, 2024, 12(11)e009805
-
Cell Rep Methods, 2023, 3(4):100440
|
|
| S2443 |
Tolbutamide (HLS 831)
|
Tolbutamide (HLS 831) is an inhibitor of potassium channel, used for type II diabetes.
|
-
Adv Healthc Mater, 2024, e2303785.
-
iScience, 2024, 27(10):110862
-
UNIVERSITY OF PÉCS, 2023,
|
|
| S1716 |
Glyburide (Glibenclamide)
|
Glyburide (Glibenclamide), a known blocker of vascular ATP-sensitive K+ channels (KATP), is used in the treatment of type 2 diabetes.
|
-
Cell Chem Biol, 2023, S2451-9456(23)00335-5
-
BMC Vet Res, 2022, 18(1):145
-
Front Cell Infect Microbiol, 2021, 11:691445
|
|
| S1658 |
Dofetilide
|
Dofetilide (UK-68798) is a selective potassium channel ((hERG)) blocker, used as a Class III antiarrhythmic drug.
|
-
Autophagy, 2025, 1-17.
-
PLoS Pathog, 2020, 16;16(3):e1008341
-
Toxicol In Vitro, 2020, 104928
|
|
| S1160 |
TRAM-34
|
TRAM-34 (Triarylmethane-34) is a selective and potent inhibitor of the intermediate-conductance Ca2+-activated K+ channel (IKCa1, KCa3.1) with Kd of 20 nM, 200- to 1500-fold selective over other ion channels, and does not block cytochrome P450.
|
-
Nat Commun, 2024, 15(1):7566
-
Pflugers Arch, 2023, 475(3):405-416
-
Cell Mol Immunol, 2022, 19(8):925-943
|
|
| S1971 |
Nicorandil
|
Nicorandil (SG-75) is a potassium channel activator, and stimulates guanylate cyclase to increase formation of cyclic GMP (cGMP).
|
-
J Immunother Cancer, 2024, 12(11)e009805
-
J Cardiovasc Pharmacol Ther, 2022, 27:10742484221088655
-
BMC Cardiovasc Disord, 2021, 21(1):302
|
|
| S2114 |
Dronedarone HCl
|
Dronedarone HCl (SR33589) is a multichannel blocker targeting potassium channel, sodium channel and calcium channel, used as an antiarrhythmic drug for treatment of atrial fibrillation (AF).
|
-
Cancers (Basel), 2022, 14(19)4883
-
Chem Res Toxicol, 2021, 10.1021/acs.chemrestox.1c00127
-
Cell Syst, 2019, 8(2):97-108
|
|
| S2825 |
ML133 HCl
|
ML133 HCl is a selective potassium channel inhibitor for Kir2.1 with IC50 of 1.8 μM (pH 7.4) and 290 nM (pH 8.5), has no effect on Kir1.1 and weak activity for Kir4.1 and Kir7.1.
|
-
Cell Mol Immunol, 2022, 19(8):925-943
-
Nat Commun, 2022, 13(1):3544
-
Mol Pain, 2019, 15:1744806919838947
|
|
| S2562 |
Hydralazine HCl
|
Hydralazine HCl is a hydrochloride salt of hydralazine, which is a direct-acting smooth muscle relaxant used to treat hypertension by acting as a vasodilator primarily in arteries and arterioles.
|
-
J Immunother Cancer, 2024, 12(11)e009805
-
Acta Pharm Sin B, 2023, 13(1):142-156
-
Acta Pharm Sin B, 2023, 13(1):142-156
|
|
| S4734 |
Retigabine 2HCl
|
Retigabine 2HCl (D-23129) is a novel anticonvulsant with activity in a broad range of seizure models. The mechanism of action involves opening of neuronal K(V)7.2-7.5 (formerly KCNQ2-5) voltage-activated K(+) channels.
|
-
J Biol Chem, 2021, S0021-9258(21)00985-6
-
Front Physiol, 2021, 12:790580
-
SSRN, 2021, 25 Pages
|
|